| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |